News on the latest health tech of Asian markets

Neurophth Completed a 130 Million Yuan A Round of Financing

Wuhan Neurophth Biotechnology Co., Ltd. (Neurophth) (Neurophth), the first Chinese company specializing in the development of ophthalmic gene therapy drugs, has completed RMB 130...

Ribo Life Science, A Leading Chinese Small Nucleic Acid Pharmaceutical Company, Received Another 470...

Ribo Life Science announced that it has received 470 million yuan in C2 financing. This round of financing was led by China ’s state-owned...

Pathology AI and Digital Pathology Company Kfbio Completes Series B Financing, Led by Intel...

Pathological artificial intelligence and digital pathology innovation company Kfbio announced that the company has completed the B round of financing, with a total financing...

CIM: New Changes in the Field of Intelligent Monitoring, Enabling Customers to Enjoy High-End...

In this epidemic, we have seen many cases of "Science and Technology War Epidemic". Intelligent robots, remote diagnosis, real-time monitoring ... The use of...

Thinmedtech Received Tens of Millions of Angel Round Financing from the Medical Union

Thinmedtech, a technology company specializing in clinical management solutions for chronic diseases, has completed tens of millions of angel rounds of financing, led exclusively...